Tamarack Advisers’s Tenet Healthcare THC Stock Holding History

Tamarack Advisers’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-50,000	Closed	-$2.97M	–	46
2023 Q1	$2.97M	Buy	+50,000	New	+$2.78M	1.09%	20

Other funds holding THC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tamarack Advisers's THC Position: Q4 2023 in Review

Tamarack Advisers sold out of Tenet Healthcare (THC) in Q4 2023, closing a stake of 20,000 shares — an estimated $1.32M sold.

Tamarack Advisers first reported a position in THC in Q3 2021 and held it in 9 quarters. The position peaked at $16.3M in Q4 2021. 425 funds tracked by Wall St. Rank hold THC as of Q4 2023.

Tamarack Advisers reported no remaining Tenet Healthcare position as of Q4 2023 after selling out during the quarter.
Tamarack Advisers sold 20,000 Tenet Healthcare shares in Q4 2023, an estimated $1.32M.
Tamarack Advisers first reported a position in Tenet Healthcare in Q3 2021 and held it in 9 quarters.
Tamarack Advisers's Tenet Healthcare position peaked at $16.3M in Q4 2021.
425 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2023.

Based on Tamarack Advisers's 13F filing for Q4 2023, filed 9 Feb 2024.